Cervera-Hernández ME, Ordaz-Vázquez A, Torres-González P, Chávez-Mazari B,Soberanis-Ramos O, Sifuentes-Osornio J, Ponce LA, Bobadilla-del Valle M

Language: English
References: 25
Page: 366-370
PDF size: 208.86 Kb.

ABSTRACT

Objective. To describe the seroprevalence and associated factors for brucellosis among dairy farm workers. Materials and methods. We performed a secondary analysis of a data set and sera from a previous cross-sectional study in a dairy farm. Sera were tested for Brucella spp. antibodies by the slide agglutination test. Seropositivity was defined as a titer ≥1:40; recent infection was titers ≥1:160. Results. We tested 331 human sera. Seroprevalence of brucellosis was 18.1% (60/331; 95% CI 14.1-22.7); 13.3% of them (8/60; 95% CI 5.9 - 24.5) corresponded to recent infection. Highexposure occupation (calf caretaker; OR 3.3; 95%CI 1.1 – 9.7), daily hours in contact with cows (OR 1.1; 95%CI 1.03 – 1.2), and living on-site (OR 2.2; 95% CI 1.1 – 4.4) remained independently associated with seropositivity. Conclusions. We found a high seroprevalence of brucellosis among dairy farm workers, as well as a significant association among those with prolonged and close contact with cattle.

REFERENCES

1. Pappas G, Papadimitriou P, Akritidis N, Christou L, Tsianos EV. The new global map of human brucellosis. Lancet Infect Dis 2006;6:91-99. http:// doi.org/d9ntw2

2. Seleem MN, Boyle SM, Sriranganathan N. Brucellosis: a re-emerging zoonosis. Vet Microbiol 2010;140:392-398. http://doi.org/cp877h

3. Franco MP, Mulder M, Gilman RH, Smits HL. Human brucellosis. Lancet Infect Dis 2007;7:775-786. http://doi.org/fhww4p

4. Pappas G, Akritidis N, Bosilkovski M, Tsianos E. Brucellosis. N Engl J Med 2005;352:2325-2336. http://doi.org/cx6jdw

5. Swai ES, Schoonman L. Human brucellosis: seroprevalence and risk factors related to high risk occupational groups in Tanga Municipality, Tanzania. Zoonoses Public Health 2009;56:183-187. http://doi.org/dksvg5

6. Rubach MP, Halliday JE, Cleaveland S, Crump JA. Brucellosis in lowincome and middle-income countries. Curr Opin Infect Dis 2013;26:404- 412. http://doi.org/bdv2

7. Lopez-Merino A, Migranas-Ortiz R, Perez-Miravete A, Magos C, Salvatierra- Izaba B, Tapia-Conyer R, et al. Seroepidemiologia de la brucelosis en Mexico. Salud Publica Mex 1992;34:230-240.

8. Torres-Padilla J, López-Merino A, García-Escamilla R, Gutiérrez-García J. Seroprevalencia de anticuerpos anti-Brucella en disponentes de sangre con fines terapéuticos en tres bancos de sangre del Instituto Mexicano del Seguro Social. Gac Med Mex 2004;140:391-398.

9. Hernandez-Bastida A, García-Ramírez P, Cruz-Estrada A, Rojo J. Seroprevalencia de brucelosis en disponentes de sangre del Hospital General de México. Rev Med Hosp Gen Mex 1999;62:107-112.

10. Luna-Martinez JE, Mejia-Teran C. Brucellosis in Mexico: current status and trends. Vet Microbiol 2002;90:19-30. http://doi.org/d94w5g

11. Dean AS, Crump L, Greter H, Hattendorf J, Schelling E, Zinsstag J. Clinical manifestations of human brucellosis: a systematic review and meta-analysis. PLoS Negl Trop Dis 2012;6:e1929.

12. Pappas G. The changing Brucella ecology: novel reservoirs, new threats. Int J Antimicrob Agents 2010;36:S8-S11. http://doi.org/cz98cq

13. Schelling E, Diguimbaye C, Daoud S, Nicolet J, Boerlin P, Tanner M, et al. Brucellosis and Q-fever seroprevalences of nomadic pastoralists and their livestock in Chad. Prev Vet Med 2003;61:279-293. http://doi.org/b2hnz4

14. Torres-Gonzalez P, Soberanis-Ramos O, Martinez-Gamboa A, Chavez- Mazari B, Barrios-Herrera MT, Torres-Rojas M, et al. Prevalence of latent and active tuberculosis among dairy farm workers exposed to cattle infected by Mycobacterium bovis. PLoS Negl Trop Dis 2013;7:e2177. http://doi.org/bdv3

15. Al Dahouk S, Sprague LD, Neubauer H. New developments in the diagnostic procedures for zoonotic brucellosis in humans. Rev Sci Tech 2013;32:177-188. http://doi.org/bdv4

16. Luce R, Snow J, Gross D, Murphy T, Grandpre J, Daley WR, et al. Brucellosis seroprevalence among workers in at-risk professions: northwestern Wyoming, 2005 to 2006. J Occup Environ Med 2012;54:1557-1560. http:// doi.org/bdv5

17. Megersa B, Biffa D, Niguse F, Rufael T, Asmare K, Skjerve E. Cattle brucellosis in traditional livestock husbandry practice in Southern and Eastern Ethiopia, and its zoonotic implication. Acta Vet Scand 2011;53:24. http://doi.org/fbpjqh

18. El Sherbini A, Kabbash I, Schelling E, El Shennawy S, Shalapy N, Elnaby GH, et al. Seroprevalences and local variation of human and livestock brucellosis in two villages in Gharbia Governorate, Egypt. Trans R Soc Trop Med Hyg 2007;101:923-928. http://doi.org/b2jspf

19. Moyer NP, Evins GM, Pigott NE, Hudson JD, Farshy CE, Feeley JC, et al. Comparison of serologic screening tests for brucellosis. J Clin Microbiol 1987;25:1969-1972.

20. Gomez MC, Nieto JA, Rosa C, Geijo P, Escribano MA, Muñoz A, et al. Evaluation of seven tests for diagnosis of human brucellosis in an area where the disease is endemic. Clin Vaccine Immunol 2008;15:1031-1033. http://doi.org/dkmxpv

21. Chart H, Okubadejo OA, Rowe B. The serological relationship between Escherichia coli O157 and Yersinia enterocolitica O9 using sera from patients with brucellosis. Epidemiol Infect 1992; 108:77-85. http://doi. org/cd4drz

22. World Health Organization. Brucellosis in humans and animals. Geneva:WHO Press, 2006: 45.

23. Perry BD, Grace D, Sones K. Current drivers and future directions of global livestock disease dynamics. Proc Natl Acad Sci USA 2013;110:20871-20877. http://doi.org/djcqgs

24. Roth F, Zinsstag J, Orkhon D, Chimed-Ochir G, Hutton G, Cosivi O, et al. Human health benefits from livestock vaccination for brucellosis: case study. Bull World Health Organ 2003;81:867-876.

25. Makita K, Fevre EM, Waiswa C, Eisler MC, Welburn SC. How human brucellosis incidence in urban Kampala can be reduced most efficiently? A stochastic risk assessment of informally-marketed milk. PLoS One 2010;5:e14188. http://doi.org/bg6382